Indiana asked a federal appeals court Monday to lift a judge's order blocking parts of a new abortion law that cuts some public Planned Parenthood funding, saying the issue should be decided by Medicaid officials and not the courts.
Deloitte found that 20 percent of consumers have cut back on health care spending and 75 percent say the economic slowdown has had some impact on their willingness to spend on health care.
With recession-weary Americans going to the doctor less, health insurer WellPoint Inc. should be enjoying higher profits. But it isn’t working out that way.
The U.S. Court of Appeals for the Federal Circuit in Washington, D.C., overturned Friday a judge’s decision that Lilly’s patent on attention-deficit treatment Strattera was invalid.
The organization that organizes medical teams to serve overseas is now called Timmy Global Health.
An investment firm projects that the Elanco animal-health business will generate sales of nearly $2 billion by 2012 and surpass $3 billion by 2018.
A state panel heard from a parade of experts Thursday as it began studying whether to legalize marijuana in Indiana or reduce criminal penalties on small amounts of the drug.
The hospital system said it will expand its Medical Center Northeast facility to a 40-bed inpatient hospital. Construction is set to begin in September and should be completed by December 2012.
Consumers may catch a little break when their health insurance policies renew. Lower-than-expected use of health care has helped push insurer earnings higher and that may temper how much they increase premiums.
The Carmel-based life and health insurer earned $59.5 million in the three months ended June 30, an increase of 80 percent from the same period a year ago.
Former Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry in Indiana to venture capital and Purdue’s Discovery Park.
Second-quarter revenue for the Indianapolis-based company increased 18 percent, to $1.5 billion. The company attributed the gain to higher prices and stronger demand for its products.
Indianapolis-based WellPoint earned $702 million in the latest quarter after earning $722 million a year ago. It also raised its full-year profit forecast.
A billboard near the Indianapolis Motor Speedway features an image of hot dogs poking out of a cigarette pack adorned with a skull and crossbones. A message warns viewers that "hot dogs can wreck your health."
Indiana health officials are targeting infant mortality, obesity, tobacco use and other health priorities in a new five-year plan aimed at improving the health of Hoosiers.
Remember Effient? The blood thinner that was once Eli Lilly and Co.’s greatest post-Zyprexa hope and then, after a slow launch, was dismissed as an abject failure? Well, it’s turning out to defy both predictions.
Indianapolis-based WellPoint claimed 63 percent of all employees covered by small-group employers and 66 percent of the workers at large-group employers, according to Seattle-based actuarial firm Milliman Inc.
Clarian Health’s recent rebranding to Indiana University Health has been good business for at least three companies in Indianapolis’ so-called measured-marketing sector. Such firms help a company overhaul its website and make changes to the “tweetosphere” and other social media channels.
Investors responded favorably Thursday to Eli Lilly and Co.’s surprisingly strong second-quarter revenue, even though its profit fell due to rapid spending on marketing and research.
Pfizer Inc., the world’s biggest drugmaker, said it isn’t interested in breaking up its animal health unit after Indianapolis-based Eli Lilly and Co. expressed interest in buying some of its products.
